These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17215475)

  • 41. Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials.
    Jensen PS; Buitelaar J; Pandina GJ; Binder C; Haas M
    Eur Child Adolesc Psychiatry; 2007 Mar; 16(2):104-20. PubMed ID: 17075688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy.
    Markowitz JS; Brown CS; Moore TR
    Ann Pharmacother; 1999 Jan; 33(1):73-85. PubMed ID: 9972387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antipsychotic agents in the treatment of bipolar mania.
    Tohen M; Vieta E
    Bipolar Disord; 2009 Jun; 11 Suppl 2():45-54. PubMed ID: 19538685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atypical antipsychotics in the treatment of mood disorders.
    Jarema M
    Curr Opin Psychiatry; 2007 Jan; 20(1):23-9. PubMed ID: 17143078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization.
    Masand PS; Culpepper L; Henderson D; Lee S; Littrell K; Newcomer JW; Rasgon N
    CNS Spectr; 2005 Oct; 10(10):suppl14 1-15. PubMed ID: 16404802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder.
    Erickson SC; Le L; Zakharyan A; Stockl KM; Harada AS; Borson S; Ramsey SD; Curtis B
    J Am Geriatr Soc; 2012 Mar; 60(3):474-9. PubMed ID: 22288652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atypical antipsychotics and mood stabilization in bipolar disorder.
    Brambilla P; Barale F; Soares JC
    Psychopharmacology (Berl); 2003 Apr; 166(4):315-32. PubMed ID: 12607072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atypical antipsychotics in elderly patients with dementia or schizophrenia: review of recent literature.
    Jeste DV; Dolder CR; Nayak GV; Salzman C
    Harv Rev Psychiatry; 2005; 13(6):340-51. PubMed ID: 16373328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of atypical antipsychotics in bipolar disorder.
    Berk M; Dodd S
    Drugs; 2005; 65(2):257-69. PubMed ID: 15631544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of special populations with the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():46-52. PubMed ID: 9766620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic syndrome associated with schizophrenia and atypical antipsychotics.
    Hasnain M; Fredrickson SK; Vieweg WV; Pandurangi AK
    Curr Diab Rep; 2010 Jun; 10(3):209-16. PubMed ID: 20425584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychiatrist and Psychiatric Pharmacists Beliefs and Preferences for Atypical Antipsychotic Treatments in Patients With Schizophrenia and Bipolar Disorders.
    Touchette DR; Gor D; Sharma D; Chennault RR; Ng-Mak DS; Rajagopalan K; Ellingrod V
    J Pharm Pract; 2021 Feb; 34(1):78-88. PubMed ID: 31238761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of olanzapine use in adolescents.
    Schulz C; Haight RJ
    Expert Opin Drug Saf; 2013 Sep; 12(5):777-82. PubMed ID: 23876012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antipsychotics in the treatment of bipolar disorder.
    Singh J; Chen G; Canuso CM
    Handb Exp Pharmacol; 2012; (212):187-212. PubMed ID: 23129333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The stable patient with schizophrenia--from antipsychotic effectiveness to adherence.
    Thomas P
    Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S115-22. PubMed ID: 17336766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atypical antipsychotics in the treatment of children and adolescents: clinical applications.
    Findling RL; McNamara NK
    J Clin Psychiatry; 2004; 65 Suppl 6():30-44. PubMed ID: 15104524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA; Nasrallah HA; Fagiolini A
    Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.